Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
暂无分享,去创建一个
C. Ayers | M. Drazner | A. Pandey | J. D. de Lemos | S. Matulevicius | J. Overton | J. Berry | A. Baras | J. Kozlitina | J. Grodin | S. Garg | Krishnasree K. Rao | Jeffrey Reid